Skip to content

ED50 and ED95 of esketamine combined with different doses of propofol for children undergoing upper gastrointestinal endoscopy

ED50 and ED95 of esketamine combined with different doses of propofol for children undergoing upper gastrointestinal endoscopy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075179
Enrollment
Unknown
Registered
2023-08-29
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

digestive tract disease

Interventions

Propofol1:Propofol 1mg/kg + Esketamine
Propofol 2:Propofol 2mg/kg + Esketamine
Propofol 3:Propofol 3mg/kg + Esketamine
Propofol 4:Propofol 4mg/kg + Esketamine

Sponsors

XuZhou Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1) Aged 3~12 years; 2) Due to dyspepsia, gastric ulcer, or other diseases need to undergo upper gastrointestinal endoscopy; 3) ASA score is I or II.

Exclusion criteria

Exclusion criteria: 1) Patients with contraindications to general anesthesia; 2) Patients who are tolerant or allergic to esketamine hydrochloride or propofol; 3) Children who are prescribed medications before anesthesia; 4) Past coagulation abnormalities and bleeding tendency; 5) Abnormal liver or kidney function or history of liver or kidney disease; 6) The investigator considers it inappropriate to participate; 7) The child or parents refuse.

Design outcomes

Primary

MeasureTime frame
Reaction when entering the endoscop;

Secondary

MeasureTime frame
examination time;awakening time;gastroenterologist's satisfaction;patient's satisfaction;heart rate;pulse oxygen saturation;mean blood pressure;

Countries

China

Contacts

Public ContactKeqing Niu

XuZhou Children's Hospital

dukenew@163.com+86 151 0520 9625

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026